SCHEMBL16746479

SCHEMBL16746479

CC1(C)c2ccccc2-c2nc(-c3cccc(-c4ccccc4)c3)nc(-c3cccc(-c4cccc(-c5ccc6oc7ccccc7c6c5)c4)c3)c21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.37
PLA2G4A P47712 4/20 0.37
PLA2G10 O15496 1/20 0.37
HSP90AA1 P07900 1/20 0.37
HSP90AB1 P08238 1/20 0.37
CHEK2 O96017 1/20 0.35
IDO1 P14902 3/20 0.34
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PRKDC P78527 1/20 0.34
CASP3 P42574 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
PIM1 P11309 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
PIM3 Q86V86 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16746477 0.99 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1
SCHEMBL17211152 0.98 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1
SCHEMBL16746470 0.98 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1
SCHEMBL17211149 0.96 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1
SCHEMBL16746483 0.94 HSP90AA1 (0.35) PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1
SCHEMBL16746475 0.91 PGR (0.39) HSP90AA1HSP90AB1CHEK2PIM1PIM2
SCHEMBL16746417 0.90 ALOX5 (0.42) PLA2G2APLA2G4APRKDCMEN1ALDH1A1
SCHEMBL16746455 0.90 ALOX5 (0.42) PLA2G2APLA2G4APRKDCMEN1ALDH1A1
SCHEMBL16746237 0.90 ALOX5 (0.42) PLA2G2APLA2G4APRKDCMEN1ALDH1A1
SCHEMBL16746491 0.90 ALOX5 (0.42) PLA2G2APLA2G4APRKDCMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11050027-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-06-29 US disclosed
US-20150144924-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2015-05-28 US disclosed
US-20150144924-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2015-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11050027-B2 Condensed cyclic compound and organic light-emitting device including the same CCNT1, CRY1, CCNA1 PLA2G2A 3282/4885PLA2G4A 3629/4885PLA2G10 3281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.